These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 11165943)

  • 1. Bone-targeted Src SH2 inhibitors block Src cellular activity and osteoclast-mediated resorption.
    Violette SM; Guan W; Bartlett C; Smith JA; Bardelay C; Antoine E; Rickles RJ; Mandine E; van Schravendijk MR; Adams SE; Lynch BA; Shakespeare WC; Yang M; Jacobsen VA; Takeuchi CS; Macek KJ; Bohacek RS; Dalgarno DC; Weigele M; Lesuisse D; Sawyer TK; Baron R
    Bone; 2001 Jan; 28(1):54-64. PubMed ID: 11165943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Src SH2 selective binding compound inhibits osteoclast-mediated resorption.
    Violette SM; Shakespeare WC; Bartlett C; Guan W; Smith JA; Rickles RJ; Bohacek RS; Holt DA; Baron R; Sawyer TK
    Chem Biol; 2000 Mar; 7(3):225-35. PubMed ID: 10712930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-based design of an osteoclast-selective, nonpeptide src homology 2 inhibitor with in vivo antiresorptive activity.
    Shakespeare W; Yang M; Bohacek R; Cerasoli F; Stebbins K; Sundaramoorthi R; Azimioara M; Vu C; Pradeepan S; Metcalf C; Haraldson C; Merry T; Dalgarno D; Narula S; Hatada M; Lu X; van Schravendijk MR; Adams S; Violette S; Smith J; Guan W; Bartlett C; Herson J; Iuliucci J; Weigele M; Sawyer T
    Proc Natl Acad Sci U S A; 2000 Aug; 97(17):9373-8. PubMed ID: 10944210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-affinity Src-SH2 ligands which do not activate Tyr(527)-phosphorylated Src in an experimental in vivo system.
    Mandine E; Jean-Baptiste V; Vayssière B; Gofflo D; Bénard D; Sarubbi E; Deprez P; Baron R; Superti-Furga G; Lesuisse D
    Biochem Biophys Res Commun; 2002 Oct; 298(2):185-92. PubMed ID: 12387813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. L-Plastin Phosphorylation: Possible Regulation by a TNFR1 Signaling Cascade in Osteoclasts.
    Chellaiah MA
    Cells; 2021 Sep; 10(9):. PubMed ID: 34572081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of unique functionalities in c-Src domains required for osteoclast podosome belt formation.
    Matsubara T; Addison WN; Kokabu S; Neff L; Horne W; Gori F; Baron R
    J Biol Chem; 2021; 296():100790. PubMed ID: 34019873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The SH2 domain: versatile signaling module and pharmaceutical target.
    Machida K; Mayer BJ
    Biochim Biophys Acta; 2005 Feb; 1747(1):1-25. PubMed ID: 15680235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Src binds cortactin through an SH2 domain cystine-mediated linkage.
    Evans JV; Ammer AG; Jett JE; Bolcato CA; Breaux JC; Martin KH; Culp MV; Gannett PM; Weed SA
    J Cell Sci; 2012 Dec; 125(Pt 24):6185-97. PubMed ID: 23097045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SH2 domain-mediated interaction of inhibitory protein tyrosine kinase Csk with protein tyrosine phosphatase-HSCF.
    Wang B; Lemay S; Tsai S; Veillette A
    Mol Cell Biol; 2001 Feb; 21(4):1077-88. PubMed ID: 11158295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro and in vivo suppression of osteoclast function by adenovirus vector-induced csk gene.
    Miyazaki T; Takayanagi H; Isshiki M; Takahashi T; Okada M; Fukui Y; Oda H; Nakamura K; Hirai H; Kurokawa T; Tanaka S
    J Bone Miner Res; 2000 Jan; 15(1):41-51. PubMed ID: 10646113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PYK2 in osteoclasts is an adhesion kinase, localized in the sealing zone, activated by ligation of alpha(v)beta3 integrin, and phosphorylated by src kinase.
    Duong LT; Lakkakorpi PT; Nakamura I; Machwate M; Nagy RM; Rodan GA
    J Clin Invest; 1998 Sep; 102(5):881-92. PubMed ID: 9727056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel bone-targeted Src tyrosine kinase inhibitor drug discovery.
    Shakespeare WC; Metcalf CA; Wang Y; Sundaramoorthi R; Keenan T; Weigele M; Bohacek RS; Dalgarno DC; Sawyer TK
    Curr Opin Drug Discov Devel; 2003 Sep; 6(5):729-41. PubMed ID: 14579523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel phosphotyrosine mimetic 4'-carboxymethyloxy-3'-phosphonophenylalanine (Cpp): exploitation in the design of nonpeptide inhibitors of pp60(Src) SH2 domain.
    Kawahata N; Yang MG; Luke GP; Shakespeare WC; Sundaramoorthi R; Wang Y; Johnson D; Merry T; Violette S; Guan W; Bartlett C; Smith J; Hatada M; Lu X; Dalgarno DC; Eyermann CJ; Bohacek RS; Sawyer TK
    Bioorg Med Chem Lett; 2001 Sep; 11(17):2319-23. PubMed ID: 11527723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein kinase N3 promotes bone resorption by osteoclasts in response to Wnt5a-Ror2 signaling.
    Uehara S; Udagawa N; Mukai H; Ishihara A; Maeda K; Yamashita T; Murakami K; Nishita M; Nakamura T; Kato S; Minami Y; Takahashi N; Kobayashi Y
    Sci Signal; 2017 Aug; 10(494):. PubMed ID: 28851822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Src homology 2 (SH2)-containing 5'-inositol phosphatase localizes to podosomes, and the SH2 domain is implicated in the attenuation of bone resorption in osteoclasts.
    Yogo K; Mizutamari M; Mishima K; Takenouchi H; Ishida-Kitagawa N; Sasaki T; Takeya T
    Endocrinology; 2006 Jul; 147(7):3307-17. PubMed ID: 16601135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. c-Src control of chloride channel support for osteoclast HCl transport and bone resorption.
    Edwards JC; Cohen C; Xu W; Schlesinger PH
    J Biol Chem; 2006 Sep; 281(38):28011-22. PubMed ID: 16831863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolation and characterization of a cDNA clone encoding a novel peptide (OSF) that enhances osteoclast formation and bone resorption.
    Reddy S; Devlin R; Menaa C; Nishimura R; Choi SJ; Dallas M; Yoneda T; Roodman GD
    J Cell Physiol; 1998 Dec; 177(4):636-45. PubMed ID: 10092216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The tyrosine phosphatase SHP-1 is a negative regulator of osteoclastogenesis and osteoclast resorbing activity: increased resorption and osteopenia in me(v)/me(v) mutant mice.
    Aoki K; Didomenico E; Sims NA; Mukhopadhyay K; Neff L; Houghton A; Amling M; Levy JB; Horne WC; Baron R
    Bone; 1999 Sep; 25(3):261-7. PubMed ID: 10495129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphorylation of the phosphatase PTPROt at Tyr
    Roth L; Wakim J; Wasserman E; Shalev M; Arman E; Stein M; Brumfeld V; Sagum CA; Bedford MT; Tuckermann J; Elson A
    Sci Signal; 2019 Jan; 12(563):. PubMed ID: 30622194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamin forms a Src kinase-sensitive complex with Cbl and regulates podosomes and osteoclast activity.
    Bruzzaniti A; Neff L; Sanjay A; Horne WC; De Camilli P; Baron R
    Mol Biol Cell; 2005 Jul; 16(7):3301-13. PubMed ID: 15872089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.